Providing evidence based information on drugs
Click me to open the menu
Click me to close the menu

schedule   x

Taking the principle of medicinal cannabis to practical implementation

5th February 2019

Medicinal cannabis is now legal in the UK, though many barriers remain to its implementation. The DrugScience Symposium discussed paths forward to facilitate patient access and data collection for scientific research.

Class A is no solution to the problem of 'monkey dust'

18th August 2018

In response to rising concern over 'monkey dust', David Nutt calls for expanded drug safety testing and a frank discussion on the roles of the UK's classification system compared to drug harms

THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost

24th January 2017

The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.

Better late than never? After 82 years the WHO reviews cannabis!

22nd December 2016

The WHO has commissioned a cannabis review before the Commission for Narcotic Drugs 2018 meeting. This will be first WHO cannabis review since 1935!

Scheduling clash: revisiting ketamine (and legislation) harms

10th December 2013

Let’s get the War on Drugs out of our hospitals and laboratories

11th June 2013

The Dustbin of Schedule 1: How Schedule 1 control may stifle medical advances

23rd January 2013

Precaution or perversion: eight harms of the precautionary principle

23rd June 2010

  • DrugScience
  • 2 Langley Lane
  • London
  • SW8 1GB
  • info@drugscience.org.uk
  • Registered Charity: 1150449